After the DNA sample is acquired from a blood or other tissues, a variety of different approaches can be used to look for mutations in your genes. The method used changes with the size of the gene and the kind of mutations that are typically found in that gene. Sometimes the whole coding sequence of the gene is examined. Other times, methods are used that only look for the most common mutations. This latter approach is often taken if the gene’s role in disease is mostly due to only a small number of known mutations. Some laboratories may use a combination of these methods by first filtering for common mutations and then, in certain situations, examining the whole coding sequence of the gene.
The Genetic testing is done by taking different test samples from body like hair, blood, saliva, tumours etc. Genetic testing is also done for some type of diseases like colon cancer, iron overload disease. The global market for genetic testing was estimated to be $XX billion in 2015and is estimated to grow at a CAGR of XX% to reach $XX billion by 2021. Laboratories, hospitals, blood banks are the major end-users for genetic testing.
The above figure depicts that Americas is leading in the genetic testing market globally in terms of revenue in 2015. The growth in this Americas is led by the development of new and advanced tests as well as increased demand for testing services in an evolving healthcare community focused on disease protection, detection and prevention. Europe and Asia-Pacific region stands next to Americas in the genetic testing market.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Genetic Testing Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Genetic Testing Market Forces
4.1. Market Drivers
4.2. Market Constraints & Challenges
4.3. Attractiveness of the Genetic Testing Industry
4.3.1. Power of Suppliers
4.3.2. Threats From New Entrants
4.3.3. Power of Buyer
4.3.4. Threat From Substitute Product
4.3.5. Degree of Competition
5. Genetic Testing Market-Strategic Analysis
5.1. Genetic Testing Market - Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunity Analysis
5.4. Product Life Cycle
5.5. Suppliers and Distributors
5.6. SWOT Analysis
6. Genetic Testing Market-By Types Of Testing
6.2. Newborn Screening
6.3. Diagnostic Testing
6.4. Carrier Testing
6.5. Prenatal Testing
6.6. Forensic Testing
6.7. Predictive and Presymptomatic Testing
7. Genetic Testing Market-By Methods
7.2. Molecular Genetic Testing
7.3. Chromosomal Genetic Testing
7.4. Biochemical Genetic Testing
8. Genetic Testing Market-By Testing Sample
9. Genetic Testing Market-By Industry
9.2. Blood Banks
9.3. Nursing Homes
10. Genetic Testing Market-By Geography
10.1. North America
10.2.5. Rest of Europe
10.3.2. South Korea
10.3.3. Australia & New Zealand
10.3.6. Rest of APAC
10.4. Rest of The World (RoW)
10.4.1. Middle East
10.4.3. South America
11. Genetic Testing Market-Entropy
11.1. New Product Developments
11.2. Product Launchers, JVs, Mergers and Acquisitions
12. Company profiles
12.2. Biocartis SA
12.3. Applied Biosystems, Inc.
12.4. Celera Group
12.5. Daan Diagnostics Ltd
12.6. Genentech, Inc.
12.7. Eastern Biotech
12.9. Perkinelmer, Inc.
12.10. Qiagen N.V.
12.11. DNA CONSULTANTS
12.12. Sorenson Genomics, LLC
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"